The abnormal continuous activation of PI3K/Akt signaling pathway was believed to be one of most important signaling pathway resulting in the resistance to both first generation and third generation of EGFR-TKIs in NSCLC patients (Hrustanovic et al. 2013; Lin et al. 2014). This evidence concerns the gene AKT1 and non-small cell lung carcinoma.